U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Cytosport Inc - 11/29/2016
  1. Warning Letters


Cytosport Inc

Cytosport Inc

United States

Issuing Office:

United States



Black HHS-Blue FDA Logo



San Francisco District
1431 Harbor Bay Parkway
Alameda, CA 94502-7070 

November 29, 2016

James P. Snee
President and Chief Executive Officer
Hormel Foods Corporate Services, LLC
1 Hormel Place
Austin, MN 55912

Dear Mr. Snee:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our June 29, 2011 Warning Letter to Cytosport Inc., located in Benicia, California. Based on our evaluation, it appears that you have addressed the violation(s) contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Lawton W. Lum
Director, Compliance Branch
San Francisco District

cc: Greg Longstreet, Chief Executive Officer of Cytosport, Inc.

Back to Top